Kigasawa et al., 1982 - Google Patents
Studies on absorption, biotransformation and excretion of drug. VIII. Metabolic fate of a new analgesic and anti-inflammatory agent, 2-oxo-3-[4-(1-oxo-2-isoindolinyl) …Kigasawa et al., 1982
- Document ID
- 12001785714244152470
- Author
- Kigasawa K
- Hiiragi M
- Maruyama K
- Tanaka M
- Ohsawa Y
- Hayashi T
- Publication year
- Publication venue
- Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan
External Links
Snippet
[Studies on absorption, biotransformation and excretion of drug. VIII. Metabolic fate of a new
analgesic and anti-inflammatory agent, 2-oxo-3-[4-(1-oxo-2-isoindolinyl)phenyl]-butanamide
(OIB) in rats] [Studies on absorption, biotransformation and excretion of drug. VIII. Metabolic …
- 239000002260 anti-inflammatory agent 0 title description 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2380032A1 (en) | CAPSULE INHALER | |
| DK195490A (en) | DISPENSES FOR POWDER-DRY MEDICINES | |
| CA2038672A1 (en) | Dosage form for delivering drug to the intestine | |
| ES8600947A1 (en) | ADMINISTRATION DEVICE FOR MEDICAL USE | |
| NO874960L (en) | LIQUID DOSAGE FOR ORAL ADMINISTRATION OF A PHARMACEUTICAL ACTIVE SUBSTANCE. | |
| DK196189A (en) | ORAL OSMOTIC DISPENSING SYSTEM CONTAINING A PHARMACOLOGICAL ACTIVE SUBSTANCE | |
| RU93036959A (en) | FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE | |
| DE3852145D1 (en) | Indole derivatives, processes for their preparation and pharmaceutical preparations containing them. | |
| PH25173A (en) | Pharmaceutical composition | |
| Knowles et al. | Absorption and excretion of 7-chloro-1, 3-dihydro-3-hydroxy-5-phenyl-2H-1, 4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection | |
| Kigasawa et al. | Studies on absorption, biotransformation and excretion of drug. VIII. Metabolic fate of a new analgesic and anti-inflammatory agent, 2-oxo-3-[4-(1-oxo-2-isoindolinyl) phenyl]-butanamide (OIB) in rats | |
| HU906301D0 (en) | Veterinary device for the introduction of medicine through the mouth of animals, and the production process of the device | |
| FR2581873B1 (en) | PHARMACEUTICAL PREPARATIONS WITH ANTI-HYPERTENSIVE AND CARDIOPROTECTIVE ACTIVITY CONTAINING VERAPAMIL, TRIAMTERENE AND HYDROCHLOROTHIAZIDE | |
| MY100780A (en) | Azumolene dosage form. | |
| MY101916A (en) | Etoposide oral dosage form. | |
| Martin et al. | A new antitumor agent,(alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4, 5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivo | |
| GR1002731B (en) | Medicinal solutions containing combinations of paracetamol and other active ingredients | |
| WO2000018370A3 (en) | Liquid pharmaceutical for oral delivery | |
| Ho et al. | Therapeutic misadventure with paracetamol | |
| DK0483320T3 (en) | Prolonged-release pharmaceutical compositions for oral administration and methods for their preparation | |
| Murata et al. | Studies on the metabolism of cytochrome c heme octapeptide (CHP). 1. Preparations of 3H-labeled CHP and 35S-labeled CHP, and absorption, distribution and excretion of these compounds in the rats and mice by means of tracer technique and whole body autoradiography | |
| Takashina et al. | Study on metabolism of the dithiol compound. II. Determination of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) and its metabolites in the blood and urine of rats and dogs | |
| JPS56122310A (en) | Suppository | |
| CA2046448A1 (en) | Dosage form for administering a drug to effect circadian therapy | |
| ATE90555T1 (en) | SCLEROGLUCAN AND PHARMACEUTICAL TABLETS AND CAPSULES GRANULES CONTAINING THE ACTIVE SUBSTANCE. |